Transfusion rates are up for renal patients

04/8/2013 | Renal and Urology News

More dialysis patients are receiving red blood cell transfusions following changes in the labeling of erythropoiesis-stimulating agents and new Medicare reimbursement practices involving end-stage renal disease, according to a study presented at a clinical meeting of the National Kidney Foundation. Researchers reviewed data on 42,790 dialysis patients and found an overall increase from 2007 to 2012. The rise has been steeper among Medicare beneficiaries than among those with private insurance since the 2011 reimbursement change.

View Full Article in:

Renal and Urology News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Food & Drug Associate
Confidential
Washington, D.C., DC